Literature DB >> 24051904

Rectal cancer: prognostic indicators of long-term outcome in patients considered for surgery.

E J Bown1, G M Lloyd, K M Boyle, A S Miller.   

Abstract

PURPOSE: Patients and clinicians seek an accurate prognosis after resectional surgery for rectal cancer. The aim of this study was to determine long-term outcomes after potentially curative surgery for rectal cancer with particular focus on factors associated with longer-term survival that are available to surgeons in the early post-operative setting.
METHODS: We conducted a retrospective review of a prospectively gathered database of all primary rectal adenocarcinomas considered for surgery in the University Hospitals of Leicester National Health Service (NHS) Trust between 1998 and 2007. Survival was calculated using a Kaplan-Meier method. Factors thought to be associated with survival were subjected to univariate analysis followed by Cox proportion regression.
RESULTS: One thousand and twelve patients with primary rectal adenocarcinoma diagnosed between 1998 and 2007 were identified. Eight hundred and fifty three patients did not have metastases at the time of presentation and 726 patients underwent major resectional surgery. Five-year survival was 66 %. Patients' age, Dukes' stage, UICC stage, nodal involvement and circumferential resection margin status were independently associated with long-term survival on multivariate analysis.
CONCLUSION: This is one of the largest series of rectal cancers from a single NHS trust. We have demonstrated that age, Dukes' stage and CRM status are associated with long-term survival. These clinical factors are readily available to the surgeon at the time of first post-operative review and can provide a good clinical guide to prognosis.

Entities:  

Mesh:

Year:  2013        PMID: 24051904     DOI: 10.1007/s00384-013-1772-z

Source DB:  PubMed          Journal:  Int J Colorectal Dis        ISSN: 0179-1958            Impact factor:   2.571


  12 in total

Review 1.  A systematic review of cancer related patient outcomes after anterior resection and abdominoperineal excision for rectal cancer in the total mesorectal excision era.

Authors:  P How; O Shihab; P Tekkis; Gina Brown; P Quirke; R Heald; B Moran
Journal:  Surg Oncol       Date:  2011-06-01       Impact factor: 3.279

2.  Comparison of circumferential margin involvement between restorative and nonrestorative resections for rectal cancer.

Authors:  P P Tekkis; A G Heriot; J Smith; M R Thompson; P Finan; J D Stamatakis
Journal:  Colorectal Dis       Date:  2005-07       Impact factor: 3.788

3.  Multicentre experience with extralevator abdominoperineal excision for low rectal cancer.

Authors:  N P West; C Anderin; K J E Smith; T Holm; P Quirke
Journal:  Br J Surg       Date:  2010-04       Impact factor: 6.939

4.  Circumferential margin involvement is still an important predictor of local recurrence in rectal carcinoma: not one millimeter but two millimeters is the limit.

Authors:  Iris D Nagtegaal; Corrie A M Marijnen; Elma Klein Kranenbarg; Cornelis J H van de Velde; J Han J M van Krieken
Journal:  Am J Surg Pathol       Date:  2002-03       Impact factor: 6.394

5.  Rectal cancer: the Basingstoke experience of total mesorectal excision, 1978-1997.

Authors:  R J Heald; B J Moran; R D Ryall; R Sexton; J K MacFarlane
Journal:  Arch Surg       Date:  1998-08

6.  Circumferential resection margin as a prognostic factor in rectal cancer.

Authors:  T E Bernstein; B H Endreseth; P Romundstad; A Wibe
Journal:  Br J Surg       Date:  2009-11       Impact factor: 6.939

7.  Evidence of the oncologic superiority of cylindrical abdominoperineal excision for low rectal cancer.

Authors:  Nicholas P West; Paul J Finan; Claes Anderin; Johan Lindholm; Torbjorn Holm; Philip Quirke
Journal:  J Clin Oncol       Date:  2008-06-09       Impact factor: 44.544

8.  The abdominoperineal resection itself is associated with an adverse outcome: the European experience based on a pooled analysis of five European randomised clinical trials on rectal cancer.

Authors:  Marcel den Dulk; Hein Putter; Laurence Collette; Corrie A M Marijnen; Joakim Folkesson; Jean-Francois Bosset; Claus Rödel; Krzysztof Bujko; Lars Påhlman; Cornelis J H van de Velde
Journal:  Eur J Cancer       Date:  2009-01-06       Impact factor: 9.162

9.  Role of circumferential margin involvement in the local recurrence of rectal cancer.

Authors:  I J Adam; M O Mohamdee; I G Martin; N Scott; P J Finan; D Johnston; M F Dixon; P Quirke
Journal:  Lancet       Date:  1994-09-10       Impact factor: 79.321

10.  Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): a multicentre, randomised trial.

Authors:  David Sebag-Montefiore; Richard J Stephens; Robert Steele; John Monson; Robert Grieve; Subhash Khanna; Phil Quirke; Jean Couture; Catherine de Metz; Arthur Sun Myint; Eric Bessell; Gareth Griffiths; Lindsay C Thompson; Mahesh Parmar
Journal:  Lancet       Date:  2009-03-07       Impact factor: 79.321

View more
  8 in total

Review 1.  Unusual osseous metastases from rectal adenocarcinoma: a case report and review of the literature.

Authors:  T M Connelly; R P Piggott; R M Waldron; P O'Grady
Journal:  J Gastrointest Surg       Date:  2015-02-27       Impact factor: 3.452

2.  Long-term oncologic outcomes of laparoscopic vs open surgery for stages II and III rectal cancer: A retrospective cohort study.

Authors:  Zhen-Xu Zhou; Li-Ying Zhao; Tian Lin; Hao Liu; Hai-Jun Deng; Heng-Liang Zhu; Jun Yan; Guo-Xin Li
Journal:  World J Gastroenterol       Date:  2015-05-14       Impact factor: 5.742

3.  Outcomes of ultra-low anterior resection combined with or without intersphincteric resection in lower rectal cancer patients.

Authors:  Jin C Kim; Chang S Yu; Seok-B Lim; Chan W Kim; In J Park; Yong S Yoon
Journal:  Int J Colorectal Dis       Date:  2015-07-05       Impact factor: 2.571

4.  Incremental Value of Radiomics in 5-Year Overall Survival Prediction for Stage II-III Rectal Cancer.

Authors:  Ke Nie; Peng Hu; Jianjun Zheng; Yang Zhang; Pengfei Yang; Salma K Jabbour; Ning Yue; Xue Dong; Shufeng Xu; Bo Shen; Tianye Niu; Xiaotong Hu; Xiujun Cai; Jihong Sun
Journal:  Front Oncol       Date:  2022-06-30       Impact factor: 5.738

5.  [Lymph node dissection after primary surgery and neoadjuvant radiochemotherapy of rectal cancer. Interim analysis of a multicenter prospective observational study (OCUM)].

Authors:  M E Kreis; C A Maurer; R Ruppert; H Ptok; J Strassburg; T Junginger; S Merkel; P Hermanek
Journal:  Chirurg       Date:  2015-12       Impact factor: 0.955

6.  Simultaneous Integrated Boost Volumetric Modulated Arc Therapy for Rectal Cancer: Long-Term Results after Protocol-Based Treatment.

Authors:  Dong Soo Lee; Seong-Taek Oh; Chang-Hyeok Ahn; Jaeim Lee; Kil-Yong Lee; Hiun Suk Chae; Sung Soo Kim; Sang Woo Kim; Kyung Jin Seo
Journal:  J Oncol       Date:  2022-04-07       Impact factor: 4.375

7.  Prognostic value of mandard and dworak tumor regression grading in rectal cancer: study of a single tertiary center.

Authors:  Marisa D Santos; Cristina Silva; Anabela Rocha; Eduarda Matos; Carlos Nogueira; Carlos Lopes
Journal:  ISRN Surg       Date:  2014-03-04

8.  Radiomics of rectal cancer for predicting distant metastasis and overall survival.

Authors:  Mou Li; Yu-Zhou Zhu; Yong-Chang Zhang; Yu-Feng Yue; Hao-Peng Yu; Bin Song
Journal:  World J Gastroenterol       Date:  2020-09-07       Impact factor: 5.742

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.